Abstract: The present invention related to the use of Cystatin in predicting onset of migraines. The invention also relates to the use of Cystatin as a vasodilatory agent. The invention also relates to antagonists to Cystatin for use in treating and preventing and treating migraine attacks.
Type:
Grant
Filed:
April 17, 2001
Date of Patent:
July 8, 2008
Assignee:
Philip-John Lamey
Inventors:
Philip-John Lamey, Fionnuala Teresa Lundy, Christopher Shaw